Optibrium has released StarDrop 7.6, an updated version of its platform for small molecule design, optimization, and analysis. The new extension, Idea Tracker, allows medicinal chemists to track molecular design and optimization decisions from idea conception to candidate selection for synthesis. Idea Tracker fills a gap in tracking the genesis and progression of initial ideas in drug design, providing a registration system for virtual compounds and enhancing workflow efficiency. This encourages collaboration and provides clear visibility of compound designs and progression, leading to better decision-making and prioritization of synthesis and testing candidates. Edmund Champness, Chief Scientific Officer at Optibrium, emphasizes the importance of collaboration in drug discovery and the company’s commitment to providing innovative solutions.
Source link
Optibrium enables collaborative design in its StarDrop platform
